Radhika Tripuraneni - Mar 10, 2025 Form 3 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Chief Medical Officer
Signature
/s/ Jennifer Tousignant, Attorney-in-fact
Stock symbol
VRDN
Transactions as of
Mar 10, 2025
Transactions value $
$0
Form type
3
Date filed
3/12/2025, 04:27 PM
Previous filing
Feb 3, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VRDN Stock Option (Right to Buy) Mar 10, 2025 Common Stock 40K $13.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 40,000 shares of the Issuer's common stock, 26,672 of which have vested, with the remaining vesting in approximately equal monthly installments through July 1, 2025, subject to the Reporting Person's continued service to the Issuer.

Remarks:

Exhibit 24 - Power of Attorney